Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis | Synapse
March 3, 2026
Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis
MN
Masoud Nikanfar
HY
Hadi Yousefi
AN
Alireza Nourazarian
Key Points
Serum miRNA-155 and TREM2 correlate with neuroinflammation in multiple sclerosis.
Significant changes in biomarkers were observed, indicating disease activity.
Assessment using serum samples from multiple sclerosis patients highlights non-invasive markers.
Findings support the use of miRNA-155 and TREM2 for therapeutic monitoring in clinical settings.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Nikanfar et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75d68c6e9836116a276eb
https://doi.org/https://doi.org/10.1007/s12035-026-05697-z
Mark Helpful
Like
Save
Bookmark
Relay
Share